The Zaleplon Market is experiencing a period of dynamic transformation as global healthcare stakeholders increasingly recognize the importance of effective treatments for sleep disorders. Zaleplon, a short-acting hypnotic agent widely prescribed for sleep-onset insomnia, is gaining traction due to its rapid onset of action and favorable safety profile compared with traditional benzodiazepines....